IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in SwedenResearch article Published on 2022-11-012022-10-05 Journal: Cytokine [Category] [DOI] 10.1016/j.cyto.2022.156020 [Article Type] Research article
JAK inhibition as a new treatment strategy for patients with COVID-19Review article Published on 2022-08-012022-10-05 Journal: Biochemical pharmacology [Category] [DOI] 10.1016/j.bcp.2022.115162 [Article Type] Review article
COVID-19 acute respiratory distress syndrome: A simulation study of the effects of combination therapy with tocilizumab and siltuximabCOVID-19 급성 호흡곤란 증후군: 토실리주맙과 실툭시맙 병용 요법의 효과에 대한 시뮬레이션 연구Article Published on 2022-03-012022-09-12 Journal: British Journal of Clinical Pharmacology [Category] [DOI] 10.1111/bcp.15009 PMC 바로가기 [Article Type] Article
A Hybrid Soluble gp130/Spike-Nanobody Fusion Protein Simultaneously Blocks Interleukin-6 trans-Signaling and Cellular Infection with SARS-CoV-2하이브리드 가용성 gp130/스파이크-나노바디 융합 단백질은 SARS-CoV-2로 인터루킨-6 트랜스-시그널링 및 세포 감염을 동시에 차단합니다Article Published on 2022-02-232022-09-12 Journal: Journal of Virology [Category] [DOI] 10.1128/JVI.01622-21 PMC 바로가기 [Article Type] Article
Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implicationsSARS-CoV-2 ARDS의 프로테아제-항-프로테아제 구획화: 치료적 의미Articles Published on 2022-02-222022-09-11 Journal: EBioMedicine [Category] [DOI] 10.1016/j.ebiom.2022.103894 PMC 바로가기 [Article Type] Articles
Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective StudyArticle Published on 2022-02-122022-10-27 Journal: Antibiotics [Category] [DOI] 10.3390/antibiotics11020241 PMC 바로가기 [Article Type] Article
Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases염증성 질환에서 하이드 록시 클로로 퀴인 및 아지트로 마이신과의 인터루킨 -6 조합의 부정맥 메커니즘Article Published on 2022-01-202022-09-01 Journal: Scientific Reports [Category] [DOI] 10.1038/s41598-022-04852-5 PMC 바로가기 [Article Type] Article
Low-dose tocilizumab is associated with improved outcome and a low risk of secondary infection in severe COVID-19 pneumonia저용량 토실리주맙은 중증 COVID-19 폐렴에서 개선된 결과 및 낮은 2차 감염 위험과 관련이 있습니다Article Published on 2021-12-012022-09-12 Journal: International journal of clinical practice [Category] [DOI] 10.1111/ijcp.14997 PMC 바로가기 [Article Type] Article
Repurposed pharmacological agents for the potential treatment of COVID-19: a literature reviewCOVID-19의 잠재적 치료를위한 용도 기반 약리학 적제 : 문헌 검토Review Published on 2021-11-272022-08-31 Journal: Respiratory Research [Category] [DOI] 10.1186/s12931-021-01885-8 PMC 바로가기 [Article Type] Review
Decreased mortality and increased side effects in COVID-19 patients treated with IL-6 receptor antagonists: systematic review and meta-analysisIL-6 수용체 길항제로 치료받은 COVID-19 환자의 사망률 감소 및 부작용 증가 : 체계적인 검토 및 메타 분석Meta-Analysis Published on 2021-11-022022-09-01 Journal: Scientific Reports [Category] [DOI] 10.1038/s41598-021-00726-4 PMC 바로가기 [Article Type] Meta-Analysis